{
    "2018-05-21": [
        [
            {
                "time": "2018-05-22",
                "original_text": "公告精选：金龙机电控股股东部分质押股份存在平仓风险；凯迪生态大股东所持28.53%股份被轮候冻结 股票质押异常",
                "features": {
                    "keywords": [
                        "金龙机电",
                        "控股股东",
                        "质押股份",
                        "平仓风险",
                        "凯迪生态",
                        "股份冻结",
                        "股票质押"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "电子设备",
                        "环保"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-05-21",
                "original_text": "复星医药：子公司草酸艾司西酞普兰片通过仿制药一致性评价",
                "features": {
                    "keywords": [
                        "复星医药",
                        "子公司",
                        "草酸艾司西酞普兰片",
                        "仿制药",
                        "一致性评价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "“入摩”名单重磅发布 医药股或成最大赢家",
                "features": {
                    "keywords": [
                        "入摩",
                        "医药股",
                        "赢家"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "22家药企开医院：人福、益佰、康美、华润…",
                "features": {
                    "keywords": [
                        "药企",
                        "医院",
                        "人福",
                        "益佰",
                        "康美",
                        "华润"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "QFII早锁定47只“入摩”股 医药股数量最多",
                "features": {
                    "keywords": [
                        "QFII",
                        "入摩",
                        "医药股"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-05-22",
                "original_text": "医药行业每周观点:从三个方向继续深挖医药投资机会,重点推荐万孚生物、葵花药业等优质标的",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资机会",
                        "万孚生物",
                        "葵花药业"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}